baber/WOPTO huggingface dataset:
Patent ES-513814-A0 (ES)
IPC: B04B5/04
Filed: 1982-07-08
Abstract: Centrifuge apparatus includes a timing and control mechanism including a piston (10) to which is attached a cam (39, 51) having cam surfaces (5) which interact with flexible tubing (36) to control the rate of flow of blood through the tubing. The velocity of the piston (10) in the centrifugal force field of rotor (34) is determined by the resistance to flow of a viscous oil which the piston displaces with cylinder (12). The movement of the cam (39, 51) is, therefore, a measure of the magnitude and duration of the centrifugal force acting to process the blood.
Patent ES-524511-A0 (ES)
IPC: A61P7/02
Filed: 1983-07-28
Abstract: 1. A process for the preparation of an inactivator which, if appropriate, is hepatitis-free and, if appropriate, can be lyophilized, of C1 esterase of the complement system (C1 inactivator) by combination of precipitation and adsorption processes which are known per se, which comprises using a carrier containing a hydrophobic group, preferably group, preferably a phenyl group, the carrier preferably being crosslinked agarose, as an adsorbent in this combination.
Patent ES-527163-A0 (ES)
IPC: C07D215/18
Filed: 1983-11-10
Abstract: The compound 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[ij]quinolizine-2-c arboxylic acid is disclosed as a potent antimicrobial agent with a broad spectrum of activity. Esters, acyl chlorides, alkylaminoalkyl ester salts and pharmaceutically acceptable carboxylate salts of the acid are also disclosed. Methods of using these compounds, pharmaceutical compositions comprising these compounds and synthetic intermediates for preparing these compounds are described.
Patent ES-532075-A0 (ES)
IPC: A61K35/16
Filed: 1984-04-30
Abstract: There is described a method of inactivating reproducible pathogens in preparations containing plasmatic enzymes and proenzymes, activated or non-activated coagulation factors, such as Factors II, V, VII, VIII, IX, X, XIII, "FEIBA", prothrombin complex preparations, plasmatic inhibitors, immunoglobulins or other blood products, such as fibronectin and fibrinogen. In order to break and overcome the protective effect of proteins on pathogens by simultaneously preserving the biological activity and the molecular integrity of the proteins, the preparation is adjusted to a salt concentration of more than 0.5 molar by the addition of ammonium sulfate and is thermally treated, whereupon the ammonium sulfate is removed from the preparation.
Patent ES-552572-A0 (ES)
IPC: A23K20/195
Filed: 1986-02-28
Abstract: Novel  beta -lactam antibiotics of the formula   <IMAGE>   in which R1, R2 and R3, which may be identical or different, denote a substituted or unsubstituted alkyl radical or a monocyclic or bicyclic, optionally substituted, carbocyclic or heterocyclic ring, or R1 represents an optionally substituted alkyl radical or a monocyclic or bicyclic, substituted or unsubstituted, carbocyclic or heterocyclic ring, and R2 and R3, together with the N(+) atom, form an optionally substituted monocyclic or polycyclic ring which can be saturated or unsaturated and can contain oxygen, sulphur and nitrogen as other hetero atoms, or R1, R2 and R3, together with the N(+) atom, form a bridged, optionally substituted polycyclic ring which can be saturated or unsaturated and can contain oxygen, sulphur and nitrogen as other hetero atoms, and R4 represents hydrogen or optionally substituted alkyl, aryl or heterocyclyl or hydroxycarbonyl, lower alkoxycarbonyl, halogen, pseudohalogen or a group of the formula <IMAGE>   in which n denotes 0, 1 or 2, and B represents a direct bond, oxygen or a group   <IMAGE>  and A and W, independently of one another, represent hydrogen or optionally substituted alkyl, aryl or heterocyclyl, or together form an optionally substituted carbocyclic or heterocyclic ring.
Patent ES-557619-A0 (ES)
IPC: A61P37/06
Filed: 1987-07-01
Abstract: Cyclosporins e.g. of formula IIin whichX is -MeBmt- or -dihydro-MeBmt- andY is -aAbu-, Thr-, -Val- or -Nva-, wherein the residue at the 3-position, i.e. the residue Z in formula II, is an optically active, a-N-methylated a-aminoacid residue of the (D)-configuration, possess pharmaceutical, in particular immunosuppressive, anti-inflammatory and anti-parasitic activity. Intermediate cyclosporin poly-anions having a de-protonated sarcosyl residue at the 3-position, e.g. polyanions of cyclosporins of formula II above wherein X and Y have the meanings given above and Z is -Sar<sub>-</sub>, in which the said residue Z is de-protonated, are also novel and part of the invention.
Patent FI-841414-A0 (FI)
Inventor: LARSSON PETER LARS
IPC: H01R4/02
Filed: 1984-04-10
Abstract: Connectors for terminating and splicing high voltage power cables comprise a metallic tubular sleeve having an open end for receiving an electrical conductor and a closed end. The inner wall of the sleeve is pretinned. The sleeve can be provided with a slug of solder proximate to the closed end. A connection is made by inserting the conductor into the sleeve, heating the solder, and as the solder melts, relatively moving the connector and the conductor toward each. The connector can be provided with an insert to accommodate conductors that are non-circular in cross-section. The connector can be provided with means for pressuring the slug of solder toward the open end of the sleeve at the temperature at which the slug of solder melts. With this connector, no relative movement between the conductor and the connector is required. Merely by melting the solder, the means for pressuring causes the solder to extrude around the conductor.
Patent FI-850328-A0 (FI)
Inventor: BERGMILLER WALTER
IPC: G07F7/02
Filed: 1985-01-25
Abstract: 1. A device for the checking and cancellation of a value card (12) insertable in a card reader (1) for terminal equipment, especially card-operated telephones, and containing value units, having the following features : the card reader (1) has a slot (13), through which the value card (12) can be pushed into a card receptacle (3) corresponding to the size of the value card (12) ; the card receptacle (3) is designed so that the value card (12) is guided by it and, at its edge extending perpendicularly relative to the direction of insertion, is touched by a push-out hook (6) ; the card receptacle (3), together with the value card (12) so retained, can, as a result of a pivoting movement, be brought up to a contact element (19) serving for checking and cancellation ; there are means which, as a result of interlocking, allow the pivoting movement only when the value card (12) is inserted far enough into the card receptacle (3) ; after the pivoting movement has been executed, the card receptacle (3) can be stopped, by means of a blocking device (20, 21, 22) actuated by a magnet system, in a position differing from the insertion position and serving for checking and cancellation, up to the completion of cancellation, and can subsequently be returned to the initial position via spring elements, the value card (12) being ejected from the card reader (1) by the push-out hook (6) after cancellation has taken place, characterised in that the push-out hook (6) forms one arm of a transport rocker (2), the other arm of which is formed by two claws (5) engaging round the value card (12) at its edge located opposite the push-out hook (6), and in that the pivoting movement takes place as a result of the interlocking of the transport rocker (2) with a drive device, the value card (12) first being drawn into the card reader (1) completely and the slot (13) being closed by means of a blocking slide (4), and then the pivoting movement taking place.
Patent FI-864503-A0 (FI)
Inventor: SCHULER HARALD WALTER
IPC: A62D1/00
Filed: 1986-11-05
Abstract: An agent (I) for fire-extinguishing and for fire-proofing organic materials comrpises an aq. soln. of pH 7.0-8.0 contg. 300-350 g/l citric acid (II) with addn. of an equimol. amt. of Na and K in the mol. ratio of 0.6-1.0:100. (I) is prepd. by dissolving 300-350 g (II) and an equimol. amt. of Na and K carbonate, bicarbonate, or hydroxide (Na:K ratio as above) in 1:1 water, and adjusting the pH as above with (II) or the other components as necessary. Pref. pH is 7.6 and Na:K ratio is 0.84:100.
Patent FI-873313-A0 (FI)
Inventor: TROSTMANN UWE
IPC: C07D241/04
Filed: 1987-07-29
Abstract: The present invention covers a novel series of 2-acyloxypropylamine derivatives, processes for preparing them, compositions containing them, and methods for using them. The compounds are active in the inhibition of protein kinase C and thrombocyto aggregation stimulated by diacylglycerols.
Patent FI-882903-A0 (FI)
Inventor: TIMPERI JUKKA
IPC: F04D7/04
Filed: 1988-06-17
Abstract: The present invention relates to a centrifugal pump for pumping of stiff and air containing liquids or various suspensions, and is characterized by considerable extension of rotor (13) of the impeller (10) of the pump so that rotor (13) extends far into the space (4) containing the material being pumped.
Patent FI-912111-A0 (FI)
Inventor: KLANK OTTO
IPC: H03J7/28
Filed: 1991-04-30
Abstract: A satellite radio receiver obtains signals from a satellite receiving installation comprising one or more frequency converters which may, for example, undergo a frequency drift as a result of temperature variations which cannot be compensated by an AFC circuit which is located in the satellite radio receiver and which controls a carrier oscillator for carrier regeneration in a demodulator circuit. According to the invention, a local oscillator for a mixer is designed as a PLL local oscillator (44) which can be tuned in a large or a small increment. The AFC circuit (1) and a synchronizing signal evaluation circuit (40) are corrected to a control circuit (34) by means of which the PLL local oscillator (44) is tuned, outside the control range of the AFC circuit (1), with a large increment in the case of undetected synchronizing signals and with a small increment in the case of detected synchronizing signals until the control range of the AFC circuit (1) is reached. The satellite radio receiver described is suitable for connection to satellite receiving installations which comprise a plurality of frequency converters and therefore deviate the nominal receiving frequency in a summary fashion and for private individual installations which, for economic reasons, possess low frequency stability.
Patent FI-924451-A0 (FI)
Inventor: BROADWIN ALAN
IPC: A61B18/14
Filed: 1992-10-02
Abstract: An improved device for delivering RF current to the operating tool of an ultrasonic surgical apparatus which comprises a switch module for selecting said RF current, an electrically conducting metal band connected to the switch module and an electrically conductive O-ring in electrical contact with the metal band and located around the acoustic conecting member of the apparatus.
Patent FI-952793-A0 (FI)
Inventor: LARSSON BO ERIK STEFAN
IPC: G06F11/14
Filed: 1995-06-07
Abstract: For backing up in a distributed real time data base on primary memory in operation, all data in the data base are structured as belonging to one of several logic data bases. The logic data can, but need not, extend over several processors. A backup function of a certain logic data base is activated by sending a message to a central backup handler, which has information regarding processors, over which the current backup system extends, and synchronizes the backup function over processor borders. The synchronization includes that local data base handlers are informed that backup will be started and that a new transaction log is being created, in which all transactions that have not attained a commit state and which shall therefore not be included in the backup are logged. The backup will only contain changes of transactions in the old transaction log.
Patent FI-956016-A0 (FI)
Inventor: URBAHNS KLAUS
IPC: C07D471/04
Filed: 1995-12-14
Abstract: Tricyclic 1,4-dihydropyridine derivatives of formula (I) are new. R1 = 6-10C aryl substituted by 0-5 of NO2, CN, halo, CF3 and 1-6C alkylthio; R2 = 1-8C alkyl, 1-8C alkoxy or phenyl; a = 1-3; and R3+R4 = CH2CH2CH2 or CH2CH(Me)CH2.
Patent IL-61054-A0 (IL)
Title: Protective filling,particularly for safe walls
IPC: E05G1/024
Filed: 1980-09-17
Abstract: A torch and drill protective filling, particularly for safe walls, consisting of a cast steel alloy grill embedded in a cast non-ferrous alloy. The safe wall filling may be formed as a discrete, separately-made element, as a part of the safe wall, or as part of the complete safe casing.
Patent IL-81733-A0 (IL)
Title: Penem derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/431
Filed: 1987-03-02
Abstract: There are provided compounds of formula I :whereinR' is hydrogen or a C<sub>1</sub>-C<sub>4</sub> alkyl group either unsubstituted or substituted by one or more substituents chosen from a free or protected hydroxy or halogen atom;R<sup>2</sup> is a free or esterified carboxy group or carboxylate anion;R<sup>3</sup> and R<sup>4</sup> are each independently hydrogen or organic group,X is,-S-,Q is either(a") free or protected hydroxy, or(b") a C<sub>1</sub>-C<sub>4</sub> acyloxy, or(c") carbamoyloxy OCONH<sub>2</sub>, or(d") an optionally substituted heterocyclylthio group, or(e") an optionally substituted imido group, or(f") an optionally substituted quaternary ammonium group or(g") a halogen atom, and the pharmaceutically or veterinarily acceptable salts thereof.There are provided also methods for preparing compounds of formula 1. The compounds of formula I are useful as antibacterial agents.
Patent IL-85109-A0 (IL)
Title: Ypsilon-glutamyl transpeptidase,its preparation and its use
IPC: C12R1/125
Filed: 1988-01-15
Abstract: Using a  gamma -glutamyltranspeptidase which can be prepared by fermentation, it is possible to hydrolyse adipinyl- or glutaryl-monoamino compounds, in particular  alpha -keto-adipinyl- or glutaryl-7-aminocephalosporanic acid.
Patent IL-94303-A0 (IL)
Title: Preparation of diazabicyclic intermediates
IPC: C07D207/10
Filed: 1990-05-06
Abstract: Diazabicyclo[2.2.1]heptane intermediates are prepared from 4-hydroxy-L-proline in a five step procedure, or from allo-4-hydroxy-D-proline, through a novel 2-(C1-c6)alkyl-5-substituted-2,5-diazabicyclo[2.2.1]heptane intermediate. The diazabicycloheptanes are of use in the preparation of antibiotic quinolones.
Patent AU-PR612001-A0 (AU)
Title: System and method for directional noise monitoring
IPC: G01S3/808
Filed: 2001-07-04
Abstract: This invention concerns environmental noise monitoring, and more particularly a system and method for environmental noise monitoring. The environmental noise monitoring system comprises three or more sound level transducers arranged apart from each other in an environment containing one or more noise sources. Each transducer is arranged to pick up sounds arriving from all directions and to transduce the sounds into electrical signals. The sound level and direction measuring equipment includes signal samplers connected to respective transducers to receive electrical signals representing environmental sounds and to sample the electrical signals. A computer processor is further provided to perform cross correlation calculations to generate a cross correlation function for each pair of sampled signals. The processor identifies local maxima in the cross correlation functions, estimates the angle of arrival of the sound associated with a local maximum and the sound pressure level associated with the maximum, and uses the estimates of the angles from all cross correlation functions to identify a source of noise in a particular direction and the level of noise from that source, and then identifies additional sources of noise in different directions and the levels of noise from those sources. Noise levels from sources in particular directions may be accumulated, displayed and saved for reference. <IMAGE>
Patent FI-20030719-A0 (FI)
Inventor: RAATIKAINEN JUHA
IPC: E05B59/00
Filed: 2003-05-14
Abstract: A door lock includes a latch bolt and an auxiliary bolt. A stop member is supported by the auxiliary bolt and is movable relative to the auxiliary bolt between a position in which it prevents a guide element moving to a position providing deadlocking of the latch bolt, while the auxiliary bolt is in a protruding position, and a position in which it allows the guide element to move to a position providing the deadlocking of the latch bolt. The stop member allows the guide element to move to the position providing deadlocking of the latch bolt only in case both the auxiliary bolt and the latch bolt are first moved to retracted positions.
Patent FI-20040264-A0 (FI)
IPC: D21F/
Filed: 2004-02-19
Abstract: A method for changing the distribution of the loading pressure prevailing in the press nip of a shoe press, which shoe press includes a number of adjacent loading elements (K) acting on the press shoe (70), the first end of the elements being supported on the supporting beam (12) of the shoe press and the other end on the press shoe (70). The loading elements (K) are moved in the machine direction (MD) in the space between the press shoe (70) and the supporting beam (12) by acting on the loading element (K) at least at the end adjacent to the press shoe in such manner that the end adjacent to the press shoe is moved in the machine direction (MD) in relation to the press shoe (70), and that the end of the loading element adjacent to the supporting beam (12) can be caused to freely assume a position in relation to the supporting beam (12), preferably at least during the transfer.
Patent IL-107144-A0 (IL)
Title: A catheter for dispensing medication
IPC: A61M25/00
Filed: 1993-09-28
Abstract: The catheter with atraumatic drug delivery tip can be sued to access remote tortuous blood vessels and to deliver defined doses of medication over a desired length of the accesses vessel. The guidewire of the catheter helps guiding the catheter to a desired location and can be used to control release of medication in axial as well as in radial direction inside the vessel. The catheter is designed with sections of different flexibility.
Patent IL-108698-A0 (IL)
Title: Novel polypeptides, nucleic acids encoding them and their use
IPC: A01K67/02
Filed: 1994-02-17
Abstract: The invention discloses nucleic acids encoding variant Bile Salt Stimulated Lipase (BSSL; EC 3.1.1.1). The encoded variant BSSL enzymes maintain catalytic activity but contain fewer glycosylation sites that full-length BSSL. This reduced glycosylation facilitates purification and characterization of recombinant BSSL proteins.
Patent IL-110161-A0 (IL)
Title: 2-[1-(1,3-thiazolin-2-yl) azetidin-3-yl] Thio-carbapenem derivatives, their preparation and pharmaceutical compositions containing them
IPC: C07D477/00
Filed: 1994-06-29
Abstract: Novel 3-Mercapto-1-(1,3-thiazolin-2-yl)azetidine derivatives represented by formula (IX) below or acid addition salts thereof <CHEM> wherein R is hydrogen, C1-C7 alkyl group which is unsubstituted or substituted by hydroxy, C1-C7 alkoxy or C1-C7 alkoxy-C1-C7 alkoxy group; group -COOR<1> (R<1> is hydrogen or C1-C7 alkyl group); or group -CONR<2>R<3> (R<2> and R<3> are, independently each other, hydrogen or C1-C7 alkyl and a process for producing these compounds.
Patent IL-113363-A0 (IL)
Title: Objects having three-dimensional surface structure and their preparation
IPC: B44C5/04
Filed: 1995-04-13
Abstract: The invention relates to a process for the preparation of articles with a three-dimensional surface structure, in which a substrate is printed, at least one of the printing inks employed for the printing being varnish-repellent, and the printed substrate is then varnished. In accordance with the invention, the printed substrate is varnished with a radiation-curable varnish which contains no amino resin and comprises A) from 18 to 99.9% by weight of an epoxy acrylate, a polyether acrylate or a polyester acrylate, B) from 0.1 to 5.0% by weight of a Br+E,uml o+EE nsted acid or an acid anhydride, C) from 0 [sic] to 12% by weight of a photoinitiator, D) from 0 to 40% by weight of water or at least one organic solvent, E) from 0 [sic] to 10% by weight of a polyol which may be ethoxylated and/or propoxylated and has from 2 to 50 carbon atoms in the molecule, and F) from 0 [sic] to 30% by weight of other auxiliaries and additives, and the varnish coat applied is cured with high-energy radiation.
Patent IL-128358-A0 (IL)
Title: Neuraminic acid compounds pharmaceutical compositions containing the same and use thereof
IPC: C07D309/28
Filed: 1997-08-12
Abstract: A neuraminic acid compound represented by the formula: <CHEM> Äwherein R<1> represents a C1-C4 group which may be substituted with a halogen atom; R<2>, R<3> and R<4> may be the same or different and each represents a hydrogen atom or a C3-C25 aliphatic acyl group; and W represents a hydrogen atom or an ester residue, provided that the case where R<1> is a methyl group and each of R<2>, R<3>, R<4> and W is a hydrogen atom is excludedÜ  or a pharmacologically acceptable salt thereof. ÄEffectÜ   The neuraminic acid compound of the present invention exhibits excellent in vivo sialidase inhibitory activity and is useful as a therapeutic agent or a preventive agent for influenza viral infections.
Patent IL-129284-A0 (IL)
Title: Multi-electrode double layer capacitor
IPC: H05K5/03
Filed: 1997-08-29
Abstract: A single cell, multi-electrode high performance double layer capacitor includes first and second flat stacks of electrodes adapted to be housed in a closeable two-part capacitor case which includes only a single electrolyte seal. Each electrode stack has a plurality of electrodes connected in parallel, with the electrodes of one stack being interleaved with the electrodes of the other stack to form an interleaved stack, and with the electrodes of each stack being electrically connected to respective capacitor terminals. A porous separator sleeve is inserted over the electrodes of one stack before interleaving to prevent electrical shorts between the electrodes. The electrodes are made by folding a compressible, low resistance, aluminum-impregnated carbon cloth, made from activated carbon fibers, around a current collector foil, with a tab of the foils of each electrode of each stack being connected in parallel and connected to the respective capacitor terminal. The height of the interleaved stack is somewhat greater than the inside height of the closed capacitor case, thereby requiring compression of the interleaved electrode stack when placed inside of the case, and thereby maintaining the interleaved electrode stack under modest constant pressure. The closed capacitor case is filled with an electrolytic solution and sealed. A preferred electrolytic solution is made by dissolving an appropriate salt into acetonitrile (CH3CN). In one embodiment, the two parts of the capacitor case are conductive and function as the capacitor terminals.
Patent IL-136359-A0 (IL)
Title: Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
IPC: C07D307/00
Filed: 1998-12-10
Abstract: Compounds of formula I,wherein Het represents a heterocycle having the meaningand R1, R2, R3 and R4 have the meanings as given in the description are novel effective bronchial therapeutics.
Patent IL-144421-A0 (IL)
Title: Purification of biological substances
IPC: C12N7/04
Filed: 2000-02-22
Abstract: A process and apparatus for purifying one or more target substances from a source liquid, employing one or more cross-flow filter elements, and one or more types of chromatography resins, in combination, to provide purification with advantageous yield, product purity, and cost-and time-efficiency.